Page last updated: 2024-09-03

ak 2123 and lonidamine

ak 2123 has been researched along with lonidamine in 1 studies

Compound Research Comparison

Studies (ak 2123)	Trials (ak 2123)	Recent Studies (post-2010) (ak 2123)	Studies (lonidamine)	Trials (lonidamine)	Recent Studies (post-2010) (lonidamine)
52	8	5	402	55	97

Protein Interaction Comparison

Protein	Taxonomy	ak 2123 (IC50)	lonidamine (IC50)
M17 leucyl aminopeptidase	Plasmodium falciparum 3D7		7.37

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Konovalova, NP	1

Other Studies

1 other study(ies) available for ak 2123 and lonidamine

Article	Year
Ultralow doses of various drugs in chemotherapy of experimental tumors. Bulletin of experimental biology and medicine, 2003, Volume: 135 Suppl 7 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Indazoles; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Mitomycin; Neoplasm Metastasis; Neoplasms, Experimental; Triazoles; Xenograft Model Antitumor Assays	2003

Article

Year

Ultralow doses of various drugs in chemotherapy of experimental tumors.

Bulletin of experimental biology and medicine, 2003, Volume: 135 Suppl 7

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Indazoles; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Mitomycin; Neoplasm Metastasis; Neoplasms, Experimental; Triazoles; Xenograft Model Antitumor Assays

2003